TRANSARTERIAL CHEMOEMBOLISATION IN INOPERABLE HEPATOCELLULAR CARCINOMA: A TERTIARY CENTRE EXPERIENCE

被引：0
|
作者：
McMahon, M. [1 ]
Popuri, R. K. [2 ]
Chalmers, N. [2 ]
Prince, M. I. [1 ]
机构：
[1] Manchester Royal Infirm, Dept Gastroenterol, Manchester M13 9WL, Lancs, England
[2] Manchester Royal Infirm, Dept Radiol, Manchester M13 9WL, Lancs, England
来源：
GUT | 2010年 / 59卷
关键词：
D O I：
10.1136/gut.2009.209056v
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A74 / A74
页数：1
相关论文
共 50 条
  • [41] Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply
    Cabibbo, G.
    Genco, C.
    Camma, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 862 - 863
  • [42] Rare pulmonary and cerebral complications after transarterial chemoembolisation for hepatocellular carcinoma: A case report
    Zhao, Hua
    Wang, Hui-Qin
    Fan, Qing-Qiu
    Chen, Xing-Xian
    Lou, Jian-Ying
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (41) : 6425 - 6427
  • [43] Comparison Between Radial and Femoral Artery Access for Transarterial Chemoembolisation in Patients With Hepatocellular Carcinoma
    Hedjoudje, Mohamed
    Barat, Maxime
    Dohan, Anthony
    Lucas, Alexandre
    Dautry, Raphael
    Coriat, Romain
    Marchese, Ugo
    Pol, Stanislas
    Parlati, Lucia
    Soyer, Philippe
    [J]. CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2024, 75 (01): : 178 - 186
  • [44] CRAFITY score is associated with overall survival in patients with hepatocellular carcinoma treated with transarterial chemoembolisation
    Veelken, Rhea
    Olbrich, Anne
    Schindler, Aaron
    Lieb, Sabine
    Fischer, Janett
    Ebel, Sebastian
    Denecke, Timm
    Berg, Thomas
    van Boemmel, Florian
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S507 - S507
  • [45] Commentary: the impact of compact lipiodolisation following transarterial chemoembolisation for hepatocellular carcinoma - authors' reply
    Kim, D. Y.
    Han, K. -H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (01) : 75 - 75
  • [46] Rare pulmonary and cerebral complications after transarterial chemoembolisation for hepatocellular carcinoma:A case report
    Hua Zhao
    [J]. World Journal of Gastroenterology, 2008, (41) : 6425 - 6427
  • [47] FOLLOW UP OF SERIAL TRANSARTERIAL CHEMOEMBOLISATION THERAPIES FOR HEPATOCELLULAR CARCINOMA OVER 3 YEARS
    Suthaharan, Ms Kajanthini
    Pembroke, Tom
    [J]. GUT, 2022, 71 : A16 - A17
  • [48] Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
    Kim, D. Y.
    Ryu, H. J.
    Choi, J. Y.
    Park, J. Y.
    Lee, D. Y.
    Kim, B. K.
    Kim, S. U.
    Ahn, S. H.
    Chon, C. Y.
    Han, K. -H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (11) : 1343 - 1350
  • [49] Identifying optimal candidates for liver resection or transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
    Zhao, Shoujie
    Zhang, Xiangnan
    Wang, Mengmeng
    Tan, Kai
    Dou, Weijia
    Fan, Qingling
    Li, Huichen
    Du, Xilin
    Liu, Lei
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (09)
  • [50] Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma
    Boulin, Mathieu
    Ciboulet, Anne
    Guiu, Boris
    Maillard, Emilie
    Bonnetain, Franck
    Minello, Anne
    Gagnaire, Alice
    Lepage, Come
    Krause, Denis
    Hillon, Patrick
    Bedenne, Laurent
    Cercueil, Jean-Pierre
    Chauffert, Bruno
    Jouve, Jean Louis
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 (11) : 905 - 911
12345